Skip to main content
ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · IEX Real-Time Price · USD
3.220
+0.190 (6.27%)
At close: Jul 26, 2024, 4:00 PM
3.290
+0.070 (2.17%)
After-hours: Jul 26, 2024, 7:47 PM EDT

ProPhase Labs Revenue

ProPhase Labs had revenue of $3.63M in the quarter ending March 31, 2024, a decrease of -81.17%. This brings the company's revenue in the last twelve months to $28.72M, down -69.59% year-over-year. In the year 2023, ProPhase Labs had annual revenue of $44.38M, down -63.81%.

Revenue (ttm)
$28.72M
Revenue Growth
-69.59%
P/S Ratio
2.14
Revenue / Employee
$254,115
Employees
113
Market Cap
61.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202344.38M-78.26M-63.81%
Dec 31, 2022122.65M43.61M55.17%
Dec 31, 202179.04M64.53M444.59%
Dec 31, 202014.51M4.64M46.96%
Dec 31, 20199.88M-3.25M-24.76%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
HOOKIPA Pharma 53.55M
Pro-Dex 49.46M
LENSAR 44.50M
Cryo-Cell International 31.64M
Celularity 14.79M
VolitionRx 797.03K
Revenue Rankings

PRPH News

More News